Recently, high IL-33 levels were reported to be associated with chronic bronchitis and frequent exacerbation of COPD patients [11,12]; blockage of the IL-33 and ST2 pathways showed promise in terms of reducing COPD exacerbation [13,14]. Here, IL33 is linked to chronic obstructive pulmonary disease.